HOX gene family was highly expressed in GBM cancer stem cells compared with parental lines, and HOX-PBX inhibition was a potential therapeutic target for GBM patients [5], and HOXD10 was targeted by hsa-miRNA-23a to inhibit glioma cell invasion [6]. The gene discussed is HOXD10; the disease is glioblastoma.